Skip to main content
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 1, Number 4, 2005

Review article

Computational ADME/Tox Modeling: Aiding Understanding and Enhancing Decision Making in Drug Design
pp. 325-345(21)
Authors: Delisle, Robert K.; Lowrie, Jeffery F.; Hobbs, Doug W.; Diller, David J.

Favourites:
ADD

In Silico ADME Prediction: Data Sets and Models
pp. 365-376(12)
Author: Colmenarejo, Gonzalo

Favourites:
ADD

Computational Chemistry, Informatics, and the Discovery of Vaccines
pp. 377-395(19)
Authors: Guan, P.; Davies, M.; Taylor, D. J.; Wan, S.; McSparron, H. M.; Hemsley, S. L.; Toseland, C.; Blythe, M. J.; Taylor, P. D.; Walshe, V.; Hattotuwagama, Channa K.; Doytchinova, Irini A.; Coveney, Peter V.; Borrow, Persephone; Flower, Darren R.< /inits>

Favourites:
ADD

A Computational and Experimental Analysis of Ligand Binding to Type 1 Collagen
pp. 397-422(26)
Authors: Vaidyanathan, J.; Vaidyanathan, T. K.; Ramasubbu, N.; Ravichandran, S.

Favourites:
ADD

The Challenge of Considering Receptor Flexibility in Ligand Docking and Virtual Screening
pp. 423-440(18)
Authors: Cavasotto, Claudio N.; Orry, Andrew J.W.; Abagyan, Ruben A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content